Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Tometich DB, Geiss C, Maconi ML, Chavez M, Hoogland AI, Li X, Nieves-Lopez A, Rodriguez Y, Bryant C, Brohl AS, Eroglu Z, Markowitz J, Tarhini AA, Hwu P, Khushalani NI, Jim HSL.
Tometich DB, et al. Among authors: geiss c.
Support Care Cancer. 2024 May 6;32(6):330. doi: 10.1007/s00520-024-08538-8.
Support Care Cancer. 2024.
PMID: 38709312